Analyst Ratings for Gracell Biotechnologies Inc (GRCL)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/22/2024 | Stifel | Ben Burnett | Downgrade | Hold (Buy) |
10.25 (11.00) |
10.25 (10.25) |
0% | Details |
| 12/27/2023 | Wells Fargo » Updated 12/28/2023 |
Yanan Zhu | Downgrade | Equal Weight (Overweight) |
10.00 (7.00) |
9.92 (10.25) |
3.33% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


